z-logo
Premium
A Markov regression random‐effects model for remission of functional disability in patients following a first stroke: A Bayesian approach
Author(s) -
Pan ShinLiang,
Wu HuiMin,
Yen Amy MingFang,
Chen Tony HsiuHsi
Publication year - 2007
Publication title -
statistics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.996
H-Index - 183
eISSN - 1097-0258
pISSN - 0277-6715
DOI - 10.1002/sim.2999
Subject(s) - covariate , deviance information criterion , gibbs sampling , markov chain monte carlo , random effects model , bayesian probability , statistics , markov chain , econometrics , regression analysis , proportional hazards model , computer science , mathematics , medicine , meta analysis
Abstract Few attempts have been made to model the dynamics of stroke‐related disability. It is possible though, using panel data and multi‐state Markov regression models that incorporate measured covariates and latent variables (random effects). This study aimed to model a series of functional transitions (following a first stroke) using a three‐state Markov model with or withoutconsidering random effects. Several proportional hazards parameterizations were considered. A Bayesian approach that utilizes the Markov Chain Monte Carlo (MCMC) and Gibbs sampling functionality of WinBUGS (a Windows‐based Bayesian software package) was developed to generate the marginal posterior distributions of the various transition parameters (e.g. the transition rates and transition probabilities). Model building and comparisons was guided by reference to the deviance information criteria (DIC). Of the four proportional hazards models considered, exponential regression was preferred because it led to the smallest deviances. Adding random effects further improved the model fit. Of the covariates considered, only age, infarct size, and baseline functional status were significant. By using our final model we were able to make individual predictions about functional recovery in stroke patients. Copyright © 2007 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here